<bill session="113" type="s" number="557" updated="2016-10-25T16:21:47Z">
  <state datetime="2013-03-13">REFERRED</state>
  <status>
    <introduced datetime="2013-03-13"/>
  </status>
  <introduced datetime="2013-03-13"/>
  <titles>
    <title type="short" as="introduced">Medication Therapy Management Empowerment Act of 2013</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to improve access to medication therapy management under part D of the Medicare program.</title>
    <title type="display">Medication Therapy Management Empowerment Act of 2013</title>
  </titles>
  <sponsor bioguide_id="H001049"/>
  <cosponsors>
    <cosponsor bioguide_id="A000368" joined="2013-08-01"/>
    <cosponsor bioguide_id="B001230" joined="2014-03-27"/>
    <cosponsor bioguide_id="B001265" joined="2013-06-04"/>
    <cosponsor bioguide_id="B000575" joined="2013-03-18"/>
    <cosponsor bioguide_id="B000944" joined="2013-03-13"/>
    <cosponsor bioguide_id="C001070" joined="2013-04-10"/>
    <cosponsor bioguide_id="C001088" joined="2013-04-16"/>
    <cosponsor bioguide_id="D000563" joined="2013-05-23"/>
    <cosponsor bioguide_id="E000285" joined="2013-06-11"/>
    <cosponsor bioguide_id="F000457" joined="2013-03-13"/>
    <cosponsor bioguide_id="G000555" joined="2013-07-11"/>
    <cosponsor bioguide_id="H001046" joined="2013-05-15"/>
    <cosponsor bioguide_id="H001069" joined="2013-09-26"/>
    <cosponsor bioguide_id="J000177" joined="2013-03-13"/>
    <cosponsor bioguide_id="K000360" joined="2013-05-22"/>
    <cosponsor bioguide_id="K000367" joined="2013-03-13"/>
    <cosponsor bioguide_id="L000550" joined="2013-05-16"/>
    <cosponsor bioguide_id="L000174" joined="2013-09-11"/>
    <cosponsor bioguide_id="M001183" joined="2013-09-30"/>
    <cosponsor bioguide_id="M000133" joined="2013-09-18"/>
    <cosponsor bioguide_id="M001176" joined="2013-09-11"/>
    <cosponsor bioguide_id="M001153" joined="2013-10-28"/>
    <cosponsor bioguide_id="P000590" joined="2013-07-23"/>
    <cosponsor bioguide_id="R000122" joined="2013-07-09"/>
    <cosponsor bioguide_id="R000307" joined="2013-03-13"/>
    <cosponsor bioguide_id="R000361" joined="2014-05-01"/>
    <cosponsor bioguide_id="R000595" joined="2013-04-11"/>
    <cosponsor bioguide_id="S000148" joined="2013-10-28"/>
    <cosponsor bioguide_id="S001184" joined="2014-03-13"/>
    <cosponsor bioguide_id="S001181" joined="2013-07-29"/>
    <cosponsor bioguide_id="T000464" joined="2013-05-09"/>
    <cosponsor bioguide_id="W000817" joined="2013-06-18"/>
    <cosponsor bioguide_id="W000802" joined="2013-04-09"/>
  </cosponsors>
  <actions>
    <action datetime="2013-03-13">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2013-03-13" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Health care quality"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2013-03-13T04:00:00Z" status="Introduced in Senate">Medication Therapy Management Empowerment Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Chief Actuary of the Centers for Medicare and Medicaid Services to report to the Secretary of Health and Human Services (HHS) and to Congress on whether or not the expansion of the definition of targeted beneficiary, with respect to medication therapy management, would, if implemented, reduce spending under Medicare. Requires the report to include a certification of any determination by the Chief Actuary that such expansion would reduce such spending.

Specifies such an expansion as targeted beneficiaries with a single chronic disease that accounts for high Medicare spending, including diabetes, hypertension, heart failure, dyslipidemia, respiratory disease (such as asthma, chronic obstructive pulmonary disease, or chronic lung disorders), bone disease-arthritis (such as osteoporosis or osteoarthritis), rheumatoid arthritis, and mental health (such as depression, schizophrenia, or bipolar disorder). (Currently a targeted beneficiary must have multiple chronic diseases.)

Requires such an expansion to take place if the report contains the certification indicated.</summary>
  <committee-reports/>
</bill>
